Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab + Radiotherapy in Elderly HNSCC
NCT07821242Phase 2Not yet recruiting
- Sponsor
- Ke Hu
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in head and neck squamous cell carcinoma (HNSCC), sponsored by Ke Hu. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
nimotuzumab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07821242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821242.